• Title/Summary/Keyword: Analgesic agent

Search Result 111, Processing Time 0.033 seconds

DA-5018, a Novel Vanilloid Type Analgesic

  • Park, Young-Ho;You, Eun-Sook;Kim, Won-Bae;Lee, Sang-Sup
    • Archives of Pharmacal Research
    • /
    • v.20 no.1
    • /
    • pp.93-95
    • /
    • 1997
  • The aim of the present study was to elucidate the mechanism of action of DA-5018 and to compare it with those of capasaicin, resiniferatoxin (ultrapotent capasaicin analog), and olvanil (systemic antinociceptive agent equipotent with capasaicin developed by Proctor & Gamble) (fig.1).

  • PDF

Seasonal Variation of Loganin from Lonicera japonica Thunb.

  • Chung , Sung-Hyun;Yim , Dong-Sool;Lee, Soo-Kyeon
    • Proceedings of the PSK Conference
    • /
    • 2003.10b
    • /
    • pp.208.3-209
    • /
    • 2003
  • Lonicerae Folium et Caulis, the folium and stem of Lonicera japonica Thunb., has been used as diuretic, stomachic, antipyretic, analgesic and anti-inflammatory agent in Korea. We isolated a main iridoid, loganin which has some important biological effects from the folium and stem of this plant. Generally, it is known that iridoid compounds have variable contents by the collecting time and a part of plant. The content of main compound is important to evaluate its quality. In order to evaluate the quality of Lonicerae Folium et Caulis, the method of quantitative determination of loganin as a reference standard compound has been developed. (omitted)

  • PDF

A Mechanism of Gastric Antiulceration by the Extract of Artemisiae asiatica (애엽 추출물의 항위궤양에 대한 기전)

  • Hwang Gwi-Seo;Lee Jung-Suk;Yun Yeo-Pyo
    • Journal of Society of Preventive Korean Medicine
    • /
    • v.1 no.1
    • /
    • pp.118-125
    • /
    • 1997
  • In oriental medicine, Artemisiae asiatica (AA) has been used as analgesic, antiinflammatory agent, and coagulatory agent. Furthermore, eupatilin, a kind of flavonoids, is known as the active principle component of AA. This study was undertaken to determine the gastric antiulceration of AA and to elucidate its mechanism. AA showed the inhibitory effect on gastric ulceration induced by EtOH/HCl and aspirin. To elucidate its mechanism, the effect of AA on lipidperoxide level in gastric mucosa, microsome lipidperoxidation, iron -dependent lipidperoxidation, and neutrophil activation were examined. It is suggested that the antiperoxidative and antineutrophil activity of AA play important roles as a possible mechanism. These results suggest that AA might have gastric antiulceration activity due to antilipidperoxdative and antineutrophil activity.

  • PDF

Synthesis of 7-[p-(Methylthio)benzoyl]-5-benzofurancetic Acid

  • Choi, Hong-Dae;Geum, Dek-Hyun;Kowan, Youn-Sil;Son, Byeng-Wha
    • Archives of Pharmacal Research
    • /
    • v.16 no.4
    • /
    • pp.343-346
    • /
    • 1993
  • A new method was described for the preparation of 7-[p-(methylthio)benzoyl]-5-benzofuranacetic acid 6, which is an analgestic agent. Methyl 5-(2, 3-di-hydobenzofuran)acetate 3 was obtained by Friedel-Crafts reaction of 2, 3-dihydrobenzofuran with methyl .alpha.-chloro-.alpha.(methylthio)actate 1 and desulfurization of 2. Tifurac 6 was synthesized from acylation of 3 with p-(methythio)benzoyl chioride followed by bromination of 4, dehydrohalogenation, and hydrolysis of 5.

  • PDF

Salicylamide Enhances Melanin Synthesis in B16F1 Melanoma Cells

  • Ito, Yusuke;Sato, Kazuomi
    • Biomolecules & Therapeutics
    • /
    • v.29 no.4
    • /
    • pp.445-451
    • /
    • 2021
  • Salicylamide, a non-steroidal anti-inflammatory drug (NSAID), is used as an analgesic and antipyretic agent. We have previously shown that several NSAIDs have anti-melanogenic properties in B16F1 melanoma cells. In contrast, we have found that salicylamide enhances melanin contents in B16F1 melanoma cells; however, the underlying mechanism is not known. Therefore, we investigated the mechanism through which salicylamide stimulates melanogenesis. Interestingly, salicylamide enhanced diphenolase activity in a cell-free assay. Western blotting and real-time RT-PCR revealed that salicylamide increased tyrosinase expression via transcriptional activation of the Mitf gene. Together, our results indicate that salicylamide could be used as an anti-hypopigmentation agent for skin and/or hair.

Synthesis and Antiinflammatory Effects of a New Tricyclic Diterpene and Its Analogues as Potent COX-2 Inhibitors

  • Suh, Young-Ger;Kim, Young-Ho;Park, Hyoung-Sup;Lee, Hye-Kyung;Park, Young-Hoon;Kim, Ji-Young;Min, Kyung-Hoon;Shin, Dong-Yun;Jun, Ra-Ok
    • Proceedings of the Korean Society of Applied Pharmacology
    • /
    • 2000.04a
    • /
    • pp.10-14
    • /
    • 2000
  • The cycloooxygenase enzymes catalyze the oxidative conversion of arachidonic acid into prostag1andin H$_2$Which mediates both benificial and pathological effects. The COX-1 is constitutively expressed in most tissues and in blood platelets wherease the expression of COX-2 isoform is induced in response to inflmmatory stimuli such as cyctokynes. Thus the identification of a novel COX-2 selective inhibitor should offer excellent antiinflammatory activity with minimal side effects such as gastrointestinal toxicity. Recently, a group of structurally unique and biologically active pimarane diterpenoids has been isolated from indigenous Korean medicinal plants. These new diterpenoids turned out to be potential analgesic and antiinflammatory agent due to their potent inhibitory activities of prostaglandin synthesis. We have also found that the inhibition of PGE$_2$synthesis is attributed to the potent COX inhibition by pimarane diterpenoid in arachidonic acid cascade. In conjunction with development of new analgesic and nonsteroidal antiinflammatory agent, a series of works on these diterpenoids have been extensively carried out in our laboratories. These efforts involve the structure-activity relationship of pimaradienoic acid, molecular modelings and COX inibitory activities as well as actiinflammatory effects of its structural analogues. In addition, the total syntheses of the new natural pimarane diterpenoids, their stereoisomers and other structural variants were intensively investigated.

  • PDF

Anti-nociceptive activity of Corylopsis gotoana (히어리의 진통(鎭痛) 효능(效能))

  • Park, Zi Won;An, Soon Young;Yun, Sun Hwa;Shin, Youn Chel;Yang, Woo In;Lee, Se Youn;Cha, Dong Seok;Jeon, Hoon
    • Korean Journal of Pharmacognosy
    • /
    • v.50 no.4
    • /
    • pp.272-276
    • /
    • 2019
  • Corylopsis gotoana has been widely used as a traditional medicine for the treatment of lots of disease including cold, edema and vomiting. However pharmacological and phytochemical studies on the C. gotoana are extremely limited. Here in this study, the author investigated the anti-nociceptive effects of the methanolic extract of Corylopsis gotoana (MCG) using various pain models. In the present study, MCG exhibited strong and dose-dependent anti-nociceptive activities on various experimental pain models including thermal nociception and chemical nociception, compared to positive control such as tramadol and indomethacin. In addition, the result from combination test using naloxone, analgesic activity of MCG was slightly reduced, indicating that MCG acts as a partial opioid receptor agonist. These results demonstrated that MCG has potent analgesic potential and thus it may be possibly used as a valuable anti-nociceptive agent.

Anti-nociceptive Effects of Sorbus alnifolia (팥배나무의 진통 효과)

  • Kim, Bong Seok;Yun, Sun Hwa;Shin, Youn Chel;Kang, Bo Hye;Park, Seung Ju;Yang, Woo In;Lee, Se Youn;Cha, Dong Seok;Jeon, Hoon
    • Korean Journal of Pharmacognosy
    • /
    • v.51 no.3
    • /
    • pp.186-191
    • /
    • 2020
  • In this study, we evaluated the anti-nociceptive activities of Sorbus alnifolia. To investigate the anti-nociceptive properties of the methanolic extract of Sorbus alnifolia (MSA), we conducted several tests using various experimental mouse pain models. Herein, MSA significantly delayed the latency time and writhing motion in the hotplate test and acetic acid test, respectively. These result indicated that MSA has an ability to manage both peripheral and central nociception. We could further confirm the analgesic effects of MSA by performing formalin test. In combination test using naloxone, a non-selective opioid receptor antagonist, analgesic activity of MSA was partly antagonized by naloxone, but not completely, indicating that the MSA acts as a partial opioid receptor agonist. Out results suggest that the S. alnifolia may be possibly used as valuable anti-nociceptive agent.

5-HT1A receptors mediate the analgesic effect of rosavin in a mouse model of oxaliplatin-induced peripheral neuropathic pain

  • Li, Daxian;Park, Sangwon;Lee, Kyungjoon;Jang, Dae Sik;Kim, Sun Kwang
    • The Korean Journal of Physiology and Pharmacology
    • /
    • v.25 no.5
    • /
    • pp.489-494
    • /
    • 2021
  • Oxaliplatin, a third-generation platinum derivative, is the mainstay of current antineoplastic medications for advanced colorectal cancer therapy. However, peripheral neuropathic complications, especially cold allodynia, undermine the life-prolonging outcome of this anti-cancer agent. Rosavin, a phenylpropanoid derived originally from Rhodiola rosea, exhibits a wide range of therapeutic properties. The present study explored whether and how rosavin alleviates oxaliplatin-induced cold hypersensitivity in mice. In the acetone drop test, cold allodynia behavior was observed from days 3 to 5 after a single injection of oxaliplatin (6 mg/kg, i.p.). Cold allodynia was significantly attenuated following rosavin treatment (10 mg/kg, i.p.). Specific endogenous 5-HT depletion by three consecutive pretreatments with parachlorophenylalanine (150 mg/kg/day, i.p.) abolished the analgesic action of rosavin; this effect was not observed following pretreatment with naloxone (opioid receptor antagonist, 10 mg/kg, i.p.). Furthermore, 5-HT1A receptor antagonist WAY-100635 (0.16 mg/kg, i.p.), but not 5-HT3 receptor antagonist MDL-72222 (1 mg/kg, i.p.), blocked rosavin-induced analgesia. These results suggest that rosavin may provide a novel approach to alleviate oxaliplatin-induced cold allodynia by recruiting the activity of 5-HT1A receptors.